114 related articles for article (PubMed ID: 12513844)
1. [ATM and Cancer].
Tang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):77-80. PubMed ID: 12513844
[TBL] [Abstract][Full Text] [Related]
2. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
Boultwood J
J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
[TBL] [Abstract][Full Text] [Related]
3. ATM gene and lymphoid malignancies.
Gumy-Pause F; Wacker P; Sappino AP
Leukemia; 2004 Feb; 18(2):238-42. PubMed ID: 14628072
[TBL] [Abstract][Full Text] [Related]
4. [Gene atm and chronic lymphocytic leukemia - review].
Zhu DX; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1242-6. PubMed ID: 18928637
[TBL] [Abstract][Full Text] [Related]
5. ATM and lymphoid malignancies; use of oriented peptide libraries to identify novel substrates of ATM critical in downstream signaling pathways.
Rathbun GA; Ziv Y; Lai JH; Hill D; Abraham RH; Shiloh Y; Cantley LC
Curr Top Microbiol Immunol; 1999; 246():267-73; discussion 274. PubMed ID: 10396065
[No Abstract] [Full Text] [Related]
6. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer.
Stankovic T; Kidd AM; Sutcliffe A; McGuire GM; Robinson P; Weber P; Bedenham T; Bradwell AR; Easton DF; Lennox GG; Haites N; Byrd PJ; Taylor AM
Am J Hum Genet; 1998 Feb; 62(2):334-45. PubMed ID: 9463314
[TBL] [Abstract][Full Text] [Related]
7. Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene.
Meyn MS
Clin Genet; 1999 May; 55(5):289-304. PubMed ID: 10422797
[TBL] [Abstract][Full Text] [Related]
8. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK
Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant N-acetyl cysteine reduces incidence and multiplicity of lymphoma in Atm deficient mice.
Reliene R; Schiestl RH
DNA Repair (Amst); 2006 Jul; 5(7):852-9. PubMed ID: 16781197
[TBL] [Abstract][Full Text] [Related]
10. ATM and genome maintenance: defining its role in breast cancer susceptibility.
Khanna KK; Chenevix-Trench G
J Mammary Gland Biol Neoplasia; 2004 Jul; 9(3):247-62. PubMed ID: 15557798
[TBL] [Abstract][Full Text] [Related]
11. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
Micol R; Ben Slama L; Suarez F; Le Mignot L; Beauté J; Mahlaoui N; Dubois d'Enghien C; Laugé A; Hall J; Couturier J; Vallée L; Delobel B; Rivier F; Nguyen K; Billette de Villemeur T; Stephan JL; Bordigoni P; Bertrand Y; Aladjidi N; Pedespan JM; Thomas C; Pellier I; Koenig M; Hermine O; Picard C; Moshous D; Neven B; Lanternier F; Blanche S; Tardieu M; Debré M; Fischer A; Stoppa-Lyonnet D;
J Allergy Clin Immunol; 2011 Aug; 128(2):382-9.e1. PubMed ID: 21665257
[TBL] [Abstract][Full Text] [Related]
12. Missense mutation and defective function of ATM in a childhood acute leukemia patient with MLL gene rearrangement.
Oguchi K; Takagi M; Tsuchida R; Taya Y; Ito E; Isoyama K; Ishii E; Zannini L; Delia D; Mizutani S
Blood; 2003 May; 101(9):3622-7. PubMed ID: 12511424
[TBL] [Abstract][Full Text] [Related]
13. The genetic defect in ataxia-telangiectasia.
Lavin MF; Shiloh Y
Annu Rev Immunol; 1997; 15():177-202. PubMed ID: 9143686
[TBL] [Abstract][Full Text] [Related]
14. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.
Spring K; Ahangari F; Scott SP; Waring P; Purdie DM; Chen PC; Hourigan K; Ramsay J; McKinnon PJ; Swift M; Lavin MF
Nat Genet; 2002 Sep; 32(1):185-90. PubMed ID: 12195425
[TBL] [Abstract][Full Text] [Related]
15. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
[TBL] [Abstract][Full Text] [Related]
16. ATM mutations in sporadic lymphoid tumours.
Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM
Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways.
Keimling M; Volcic M; Csernok A; Wieland B; Dörk T; Wiesmüller L
FASEB J; 2011 Nov; 25(11):3849-60. PubMed ID: 21778326
[TBL] [Abstract][Full Text] [Related]
18. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL.
Luo L; Lu FM; Hart S; Foroni L; Rabbani H; Hammarström L; Yuille MR; Catovsky D; Webster AD; Vorechovský I
Cancer Res; 1998 Jun; 58(11):2293-7. PubMed ID: 9622061
[TBL] [Abstract][Full Text] [Related]
19. Cancer risk and the ATM gene: a continuing debate.
Khanna KK
J Natl Cancer Inst; 2000 May; 92(10):795-802. PubMed ID: 10814674
[TBL] [Abstract][Full Text] [Related]
20. The ATM-dependent DNA damage signaling pathway.
Kitagawa R; Kastan MB
Cold Spring Harb Symp Quant Biol; 2005; 70():99-109. PubMed ID: 16869743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
